Immunomodulatory Effects of Pure Cylindrospermopsin in Rats Orally Exposed for 28 Days. 2022

Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
Area of Toxicology, Faculty of Pharmacy, Universidad de Sevilla, 41012 Seville, Spain.

Cylindrospermopsin (CYN) is a ubiquitous cyanotoxin showing increasing incidence worldwide. CYN has been classified as a cytotoxin and, among its toxic effects, its immunotoxicity is scarcely studied. This work investigates for the first time the influence of oral CYN exposure (18.75; 37.5 and 75 µg/kg b.w./day, for 28 days) on the mRNA expression of selected interleukin (IL) genes (IL-1β, IL-2, IL-6, Tumor Necrosis Factor alpha (TNF-α), Interferon gamma (IFN-γ)) in the thymus and the spleen of male and female rats, by quantitative real-time polymerase chain reaction (RT-qPCR). Moreover, their serum levels were also measured by a multiplex-bead-based immunoassay, and a histopathological study was performed. CYN produced immunomodulation mainly in the thymus of rats exposed to 75 μg CYN/kg b.w./day in both sexes. However, in the spleen only IL-1β and IL-2 (males), and TNF-α and IFN-γ (females) expression was modified after CYN exposure. Only female rats exposed to 18.75 μg CYN/kg b.w./day showed a significant decrease in TNF-α serum levels. There were no significant differences in the weight or histopathology in the organs studied. Further research is needed to obtain a deeper view of the molecular mechanisms involved in CYN immunotoxicity and its consequences on long-term exposures.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008297 Male Males
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005260 Female Females
D000087522 Cyanobacteria Toxins Toxic secondary metabolites produced CYANOBACTERIA. Cyanobacterial Neurotoxin,Cyanobacterial Neurotoxins,Cyanobacterial Toxins,Cyanotoxins,Neurotoxin, Cyanobacterial
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
September 2013, International immunopharmacology,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
June 2012, Toxicology and applied pharmacology,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
February 1991, Archives of environmental contamination and toxicology,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
April 2023, Toxins,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
November 2012, Chemosphere,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
August 2009, Environmental science & technology,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
August 2004, Toxicology,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
February 1982, Environmental research,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
July 2019, Chemosphere,
Leticia Diez-Quijada, and Antonio Casas-Rodriguez, and Remedios Guzmán-Guillén, and Verónica Molina-Hernández, and Rafael G Albaladejo, and Ana María Cameán, and Angeles Jos
November 2011, Ecotoxicology (London, England),
Copied contents to your clipboard!